Part,  Chapter, Paragraph

1   II,     5.  5.  1|         J and the ESEMED/MHEDEA Investigators (2006). Risk factors for
2   II,     5.  5.  1|          the ESEMeD/MHEDEA 2000 Investigators (2007). Differences in lifetime
3   II,     5.  7.  3|        ESRD, have prompted some investigators to suggest that treatment
4   II,     5.  7.  3|        ESRD, have prompted some investigators to suggest that treatment
5   II,     5.  7.  5| excretion has been advocated by investigators in Groningen (The Netherlands)
6  III,    10.  2.  1| overweight and obesity. Various investigators (Branca et al, 2007a; Branca